Press-release for stocks for bdx

BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris™ Infusion System
Published: 2023-07-24 (Crawled : 12:20) - biospace.com/
BDX | $233.15 0.41% 0.15% 890K

| -12.77% | O: 6.55% H: 1.81% C: -0.79%
fda ceo clearance system

BD Receives FDA 510(k) Clearance for First-of-Its-Kind High-Throughput Diagnostic Test for Infectious Vaginitis
Published: 2023-03-16 (Crawled : 12:20) - biospace.com/
BDX | $233.15 0.41% 0.15% 890K

| -1.48% | O: -0.52% H: 2.22% C: 2.04%
fda test diagnostic clearance infectious vaginitis

BD Introduces High-Throughput Single-Cell Multiomics Platform to Expand Scope of Scientific Discovery
Published: 2023-02-03 (Crawled : 12:20) - prnewswire.com
BDX | $233.15 0.41% 0.15% 890K

| -7.03% | O: 0.05% H: 0.71% C: -1.11%
platform

BD Introduces Fully Automated Robotic Track System for Microbiology Labs
Published: 2023-01-11 (Crawled : 12:20) - biospace.com/
BDX | $233.15 0.41% 0.15% 890K

| -9.54% | O: 0.29% H: 0.25% C: 0.02%
system

Cannula Market Is Expected To Reach US$ 250 Million, Growing At A CAGR of 6.2% By 2032| Reveals Fact.MR
Published: 2022-10-14 (Crawled : 12:20) - prnewswire.com
SYK | $327.45 -2.55% 0.0% 2.1M

| 56.95% | O: 1.06% H: 0.26% C: -3.35%
MDT | $79.19 0.14% 0.0% 6.1M

| -5.29% | O: 0.73% H: 0.7% C: -2.97%
CNMD | $71.08 -2.31% 0.0% 620K

| -0.51% | O: 0.46% H: 0.97% C: -2.75%
BSX | $67.42 -0.8% -0.53% 5.9M

| 67.09% | O: 0.74% H: 0.69% C: -1.65%
BDX | $233.15 0.41% 0.15% 890K

| 1.98% | O: 0.71% H: 0.71% C: -1.5%
CNMD | $71.08 -2.31% 0.0% 620K

| -0.51% | O: 0.46% H: 0.97% C: -2.75%
growing expected market

Babson Diagnostics Welcomes Four New Leaders to Management Team
Published: 2022-09-20 (Crawled : 12:20) - biospace.com/
BDX | $233.15 0.41% 0.15% 890K

| -8.06% | O: -0.45% H: 0.08% C: -2.41%
management diagnostics

BD Earns Recognition as a Best Place to Work for Disability Inclusion
Published: 2022-07-20 (Crawled : 12:20) - prnewswire.com
BDX | $233.15 0.41% 0.15% 890K

| -3.12% | O: -0.84% H: 0.53% C: 0.31%
work